Petros Pharmaceuticals Stock Price Prediction
| PTPI Stock | USD 0.01 0.0004 5.00% |
Momentum 43
Sell Extended
Oversold | Overbought |
Using Petros Pharmaceuticals hype-based prediction, you can estimate the value of Petros Pharmaceuticals from the perspective of Petros Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Petros Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Petros because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Petros Pharmaceuticals after-hype prediction price | USD 0.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Petros |
Petros Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Petros Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Petros Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Petros Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Petros Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Petros Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Petros Pharmaceuticals' historical news coverage. Petros Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 10.77, respectively. We have considered Petros Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Petros Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Petros Pharmaceuticals is based on 3 months time horizon.
Petros Pharmaceuticals Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Petros Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Petros Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Petros Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.88 | 10.62 | 0.13 | 0.00 | 5 Events / Month | 3 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.01 | 31.58 |
|
Petros Pharmaceuticals Hype Timeline
Petros Pharmaceuticals is at this time traded for 0.01. The entity has historical hype elasticity of 0.13, and average elasticity to hype of competition of 0.0. Petros is projected to increase in value after the next headline, with the price projected to jump to 0.01 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is estimated to be 31.58%, whereas the daily expected return is at this time at -0.88%. The volatility of related hype on Petros Pharmaceuticals is about 1062000.0%, with the expected price after the next announcement by competition of 0.01. Petros Pharmaceuticals currently holds 7.39 M in liabilities with Debt to Equity (D/E) ratio of 0.31, which is about average as compared to similar companies. Petros Pharmaceuticals has a current ratio of 3.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Petros Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Petros Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Petros Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Petros to invest in growth at high rates of return. When we think about Petros Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projected press release will be in about 5 days. Check out Petros Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Petros Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Petros Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Petros Pharmaceuticals' future price movements. Getting to know how Petros Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Petros Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SISI | Shineco | 0.00 | 0 per month | 0.00 | (0) | 42.86 | (36.67) | 114.83 | |
| HEPA | Hepion Pharmaceuticals | (0.06) | 21 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IVF | INVO Fertility | 0.00 | 0 per month | 0.00 | (0.01) | 12.22 | (16.50) | 207.78 | |
| LIXT | Lixte Biotechnology Holdings | 0.15 | 10 per month | 0.00 | (0.10) | 7.19 | (7.45) | 19.11 | |
| CELU | Celularity | 0.02 | 7 per month | 0.00 | (0.13) | 9.01 | (8.97) | 26.97 | |
| SYRA | Syra Health Corp | 0.00 | 0 per month | 6.05 | 0.07 | 20.00 | (13.00) | 36.75 | |
| PKBO | Ignyte Acquisition Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XAGE | Longevity Health Holdings | 0.00 | 0 per month | 0.00 | (0.07) | 18.75 | (20.45) | 46.80 | |
| CCM | Concord Medical Services | (0.12) | 11 per month | 0.00 | (0.02) | 12.41 | (9.32) | 24.63 | |
| PETV | PetVivo Holdings | 0.00 | 0 per month | 0.00 | (0.12) | 7.55 | (9.82) | 32.58 |
Petros Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Petros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Petros using various technical indicators. When you analyze Petros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Petros Pharmaceuticals Predictive Indicators
The successful prediction of Petros Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Petros Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Petros Pharmaceuticals based on analysis of Petros Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Petros Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Petros Pharmaceuticals's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Petros Pink Sheet analysis
When running Petros Pharmaceuticals' price analysis, check to measure Petros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petros Pharmaceuticals is operating at the current time. Most of Petros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |